German biotech founder shows profitability without venture capital, arguing that the real bottleneck for startups is founder capability, not funding
Executive summary: Philipp Baaske built a biotech startup without external venture capital and achieved profitability after two years, asserting that the perceived capital shortage in Germany is actually a founder problem. The statement questions the effectiveness of current funding‑focused policies and highlights founder skill gaps as a potential barrier to scaling German startups.
Who is involved: Philipp Baaske (founder of the biotech company), German startup ecosystem, venture‑capital community, and policymakers.
Likely next: Founders and investors may increase scrutiny of founder training initiatives, while policymakers could experiment with programs that enhance entrepreneurial capabilities alongside traditional financing measures.
Philipp Baaske’s bootstrapped biotech firm reached profit within two years, challenging the narrative that German startups suffer from a capital shortage. He contends that many founders lack the skills or mindset to build scalable businesses, shifting the focus to entrepreneurial quality. The claim adds to an ongoing debate about whether policy should improve founder education and support rather than merely increase venture‑capital supply. If validated, it could redirect public and private resources toward mentorship programs and founder‑centric incubators.
Timeline
- — Start-ups: „Deutschland hat kein Kapital-, sondern ein Gründerproblem“ (Handelsblatt)
Analysis — what this means
Likely next events
- Policymakers debate introducing an experimentation year for founders, as advocated in the July 31 Gastkommentar.
- Apnimed’s upsized IPO pricing announced July 30 2026 sets the offer price for the upcoming listing.
- Black Forest Labs founder reiterates that Anthropic and OpenAI lack a secret formula, influencing ongoing AI model comparisons.
Sectors affected
- Biotech venture capital
- AI foundation model sector
- Founder training programs
- Healthcare IPO market
Historical parallels
- 2016 German ‘Startupgesetz’ aimed to reduce bureaucracy and improve access to capital for founders.
- 2021 EU Startup and Scale‑up Initiative to improve financing and talent for early‑stage companies.
- 2000 dot‑com bust highlighted founder skill gaps as many well‑funded startups failed due to weak execution.